Renal Therapeutic Market by Type, Application, Key Players and Regions - Global Industry Analysis & Forecast to 2027
Published On : August 2022 Pages : 158 Category: Medical Devices Report Code : HC0817442
The global Renal Therapeutic Market is valued at USD XX billion in 2021 and is projected to reach USD XX billion by the end of 2027, growing at a CAGR of XX% during the period 2022 to 2027.
The report exhibit detail coverage of Renal Therapeutic industry and market trends. The report also analyses present and past market values to forecast potential market through the forecast period between 2017-2022. This research study of Renal Therapeutic Market involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
In addition, the report provides insight into main drivers, challenges, opportunities and risk of the market and strategies of suppliers. Key players are profiled as well. Overall, this report covers the historical situation, present status and the future prospects of the global Renal Therapeutic Market for 2017-2022.
Crystal Market Research envisions that the span of the Renal Therapeutic Market will develop amid the estimated time frame as the Compound Annual Growth Rate boosts significantly. The objective of the market research report is the current status of the market and in accordance classifies it into a few portions. The report takes into consideration the prime market players in every area from over the globe.
Our research study analyses the size of the global market of Renal Therapeutic in primary regions such as North America, South America, Middle East & Africa, Asia Pacific and Europe. It also classifies the Renal Therapeutic Market by key manufacturers, region, type and application. Furthermore, this study examines in the status of the market, market share, future trends, growth rate, competitive landscape, opportunities, market driving factors and restraints, and challenges.
To stay updated with the latest technology and functions of the industry, Crystal Market Research regularly performs interviews with several industry experts and visits for its expert research analysts. The data sources include but not limited to reports of company’s, international organizations and governments, MMI market surveys, and related industry news.
This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2017 to 2027. This report has segmented the Renal Therapeutic Market on the basis of fabric, product, application, and region:
By Region
- North America (US, Canada)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Mexico, Columbia, Rest of South America)
- Middle East and Africa (Saudi Arabia, UAE, South Africa, Turkey, Rest of MEA)
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Vifor Pharma Inc.
- Pfizer Inc.
- Merck & Co., Inc.
- Bayer AG
- Bristol-Myers Squibb Company
- Johnson & Johnson Services, Inc.
- Novartis AG
- Amgen Inc.
- Vifor Pharma Group
- AstraZeneca
Market Classification
· Renal Therapeutic Market, By Type
o Calcium Channel Blockers
o Beta-blockers
o Angiotensin-II Receptor Blockers
o ACE Inhibitors
o Others
· Renal Therapeutic Market, By Application
o Renal Failure
o Kidney Stone Disease
o Diabetes
o Chronic Kidney Disease
o Others
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Data Mining
1.2.2. Market Modeling and Forecasting
1.2.3. Data Validation
1.2.4. Industry Analysis
2. Market Dashboard
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
4. Renal Therapeutic Market, By Type
4.1. Introduction
4.2. Renal Therapeutic Market and Market Growth Rate By Type (2017-2022)
4.3. Calcium Channel Blockers
4.3.1. Global Calcium Channel Blockers Market and Growth Rate (2017-2022)
4.3. Beta-blockers
4.3.1. Global Beta-blockers Market and Growth Rate (2017-2022)
4.3. Angiotensin-II Receptor Blockers
4.3.1. Global Angiotensin-II Receptor Blockers Market and Growth Rate (2017-2022)
4.3. ACE Inhibitors
4.3.1. Global ACE Inhibitors Market and Growth Rate (2017-2022)
4.3. Others
4.3.1. Global Others Market and Growth Rate (2017-2022)
5. Renal Therapeutic Market, By Application
5.1. Introduction
5.2. Renal Therapeutic Market and Market Growth Rate By Application (2017-2022)
5.3. Renal Failure
5.3.1. Global Renal Failure Market and Growth Rate (2017-2022)
5.3. Kidney Stone Disease
5.3.1. Global Kidney Stone Disease Market and Growth Rate (2017-2022)
5.3. Diabetes
5.3.1. Global Diabetes Market and Growth Rate (2017-2022)
5.3. Chronic Kidney Disease
5.3.1. Global Chronic Kidney Disease Market and Growth Rate (2017-2022)
5.3. Others
5.3.1. Global Others Market and Growth Rate (2017-2022)
7. Renal Therapeutic Market, By Region
7.1. Introduction
7.2. Renal Therapeutic Market and Growth Rate By Regions
6.3. North America
7.3.1. North America Renal Therapeutic Market and Growth Rate (2017-2022))
7.3.2. North America Renal Therapeutic Market By Type (2017-2022)
7.3.2. North America Renal Therapeutic Market By Application (2017-2022)
7.3.4. North America Renal Therapeutic Market By Country (2017-2022)
7.3.5. United States
7.3.5.1.United States Renal Therapeutic Market and Growth Rate (2017-2022)
7.3.5.2.United States Renal Therapeutic Market By Type (2017-2022)
7.3.5.2.United States Renal Therapeutic Market By Application (2017-2022)
7.3.5. Canada
7.3.5.1.Canada Renal Therapeutic Market and Growth Rate (2017-2022)
7.3.5.2.Canada Renal Therapeutic Market By Type (2017-2022)
7.3.5.2.Canada Renal Therapeutic Market By Application (2017-2022)
6.3. Europe
8.3.1. Europe Renal Therapeutic Market and Growth Rate (2017-2022))
8.3.2. Europe Renal Therapeutic Market By Type (2017-2022)
8.3.2. Europe Renal Therapeutic Market By Application (2017-2022)
8.3.4. Europe Renal Therapeutic Market By Country (2017-2022)
8.3.5. Germany
8.3.5.1.Germany Renal Therapeutic Market and Growth Rate (2017-2022)
8.3.5.2.Germany Renal Therapeutic Market By Type (2017-2022)
8.3.5.2.Germany Renal Therapeutic Market By Application (2017-2022)
8.3.5. France
8.3.5.1.France Renal Therapeutic Market and Growth Rate (2017-2022)
8.3.5.2.France Renal Therapeutic Market By Type (2017-2022)
8.3.5.2.France Renal Therapeutic Market By Application (2017-2022)
8.3.5. UK
8.3.5.1.UK Renal Therapeutic Market and Growth Rate (2017-2022)
8.3.5.2.UK Renal Therapeutic Market By Type (2017-2022)
8.3.5.2.UK Renal Therapeutic Market By Application (2017-2022)
8.3.5. Russia
8.3.5.1.Russia Renal Therapeutic Market and Growth Rate (2017-2022)
8.3.5.2.Russia Renal Therapeutic Market By Type (2017-2022)
8.3.5.2.Russia Renal Therapeutic Market By Application (2017-2022)
8.3.5. Italy
8.3.5.1.Italy Renal Therapeutic Market and Growth Rate (2017-2022)
8.3.5.2.Italy Renal Therapeutic Market By Type (2017-2022)
8.3.5.2.Italy Renal Therapeutic Market By Application (2017-2022)
8.3.5. Rest of Europe
8.3.5.1.Rest of Europe Renal Therapeutic Market and Growth Rate (2017-2022)
8.3.5.2.Rest of Europe Renal Therapeutic Market By Type (2017-2022)
8.3.5.2.Rest of Europe Renal Therapeutic Market By Application (2017-2022)
6.3. Asia-Pacific
9.3.1. Asia-Pacific Renal Therapeutic Market and Growth Rate (2017-2022))
9.3.2. Asia-Pacific Renal Therapeutic Market By Type (2017-2022)
9.3.2. Asia-Pacific Renal Therapeutic Market By Application (2017-2022)
9.3.4. Asia-Pacific Renal Therapeutic Market By Country (2017-2022)
9.3.5. China
9.3.5.1.China Renal Therapeutic Market and Growth Rate (2017-2022)
9.3.5.2.China Renal Therapeutic Market By Type (2017-2022)
9.3.5.2.China Renal Therapeutic Market By Application (2017-2022)
9.3.5. Japan
9.3.5.1.Japan Renal Therapeutic Market and Growth Rate (2017-2022)
9.3.5.2.Japan Renal Therapeutic Market By Type (2017-2022)
9.3.5.2.Japan Renal Therapeutic Market By Application (2017-2022)
9.3.5. Korea
9.3.5.1.Korea Renal Therapeutic Market and Growth Rate (2017-2022)
9.3.5.2.Korea Renal Therapeutic Market By Type (2017-2022)
9.3.5.2.Korea Renal Therapeutic Market By Application (2017-2022)
9.3.5. India
9.3.5.1.India Renal Therapeutic Market and Growth Rate (2017-2022)
9.3.5.2.India Renal Therapeutic Market By Type (2017-2022)
9.3.5.2.India Renal Therapeutic Market By Application (2017-2022)
9.3.5. Southeast Asia
9.3.5.1.Southeast Asia Renal Therapeutic Market and Growth Rate (2017-2022)
9.3.5.2.Southeast Asia Renal Therapeutic Market By Type (2017-2022)
9.3.5.2.Southeast Asia Renal Therapeutic Market By Application (2017-2022)
9.3.5. Rest of Asia-Pacific
9.3.5.1.Rest of Asia-Pacific Renal Therapeutic Market and Growth Rate (2017-2022)
9.3.5.2.Rest of Asia-Pacific Renal Therapeutic Market By Type (2017-2022)
9.3.5.2.Rest of Asia-Pacific Renal Therapeutic Market By Application (2017-2022)
6.3. South America
10.3.1. South America Renal Therapeutic Market and Growth Rate (2017-2022))
10.3.2. South America Renal Therapeutic Market By Type (2017-2022)
10.3.2. South America Renal Therapeutic Market By Application (2017-2022)
10.3.4. South America Renal Therapeutic Market By Country (2017-2022)
10.3.5. Brazil
10.3.5.1.Brazil Renal Therapeutic Market and Growth Rate (2017-2022)
10.3.5.2.Brazil Renal Therapeutic Market By Type (2017-2022)
10.3.5.2.Brazil Renal Therapeutic Market By Application (2017-2022)
10.3.5. Mexico
10.3.5.1.Mexico Renal Therapeutic Market and Growth Rate (2017-2022)
10.3.5.2.Mexico Renal Therapeutic Market By Type (2017-2022)
10.3.5.2.Mexico Renal Therapeutic Market By Application (2017-2022)
10.3.5. Columbia
10.3.5.1.Columbia Renal Therapeutic Market and Growth Rate (2017-2022)
10.3.5.2.Columbia Renal Therapeutic Market By Type (2017-2022)
10.3.5.2.Columbia Renal Therapeutic Market By Application (2017-2022)
10.3.5. Rest of South America
10.3.5.1.Rest of South America Renal Therapeutic Market and Growth Rate (2017-2022)
10.3.5.2.Rest of South America Renal Therapeutic Market By Type (2017-2022)
10.3.5.2.Rest of South America Renal Therapeutic Market By Application (2017-2022)
6.3. Middle East and Africa
11.3.1. Middle East and Africa Renal Therapeutic Market and Growth Rate (2017-2022))
11.3.2. Middle East and Africa Renal Therapeutic Market By Type (2017-2022)
11.3.2. Middle East and Africa Renal Therapeutic Market By Application (2017-2022)
11.3.4. Middle East and Africa Renal Therapeutic Market By Country (2017-2022)
11.3.5. Saudi Arabia
11.3.5.1.Saudi Arabia Renal Therapeutic Market and Growth Rate (2017-2022)
11.3.5.2.Saudi Arabia Renal Therapeutic Market By Type (2017-2022)
11.3.5.2.Saudi Arabia Renal Therapeutic Market By Application (2017-2022)
11.3.5. United Arab Emirates
11.3.5.1.United Arab Emirates Renal Therapeutic Market and Growth Rate (2017-2022)
11.3.5.2.United Arab Emirates Renal Therapeutic Market By Type (2017-2022)
11.3.5.2.United Arab Emirates Renal Therapeutic Market By Application (2017-2022)
11.3.5. South Africa
11.3.5.1.South Africa Renal Therapeutic Market and Growth Rate (2017-2022)
11.3.5.2.South Africa Renal Therapeutic Market By Type (2017-2022)
11.3.5.2.South Africa Renal Therapeutic Market By Application (2017-2022)
11.3.5. Rest of Middle East and Africa
11.3.5.1.Rest of Middle East and Africa Renal Therapeutic Market and Growth Rate (2017-2022)
11.3.5.2.Rest of Middle East and Africa Renal Therapeutic Market By Type (2017-2022)
11.3.5.2.Rest of Middle East and Africa Renal Therapeutic Market By Application (2017-2022)
7. Company Profiles
7.1. Vifor Pharma Inc.
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Pfizer Inc.
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Merck & Co., Inc.
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Bayer AG
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Bristol-Myers Squibb Company
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Johnson & Johnson Services, Inc.
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Novartis AG
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Amgen Inc.
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Vifor Pharma Group
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. AstraZeneca
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|